In addition, autoantibodies against calpastatin, a natural and specific inhibitor of calpain, are widely observed in RA and psoriasis patients [19], [20], [21], and positivity for anti-calpastatin antibodies is known to correlate with serological markers of the disease activity [23], [24]. This evidence concerns the gene CAST and rheumatoid arthritis.